Li Hongsen, Gong Liu, Cheng Huanqing, Wang Huina, Zhang Xiaochen, Rao Chuangzhou, Song Zhangfa, Wang Da, Lou Haizhou, Lou Feng, Cao Shanbo, Pan Hongming, Fang Yong
Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Prenatal Diagnosis Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
Front Oncol. 2022 Apr 20;12:813253. doi: 10.3389/fonc.2022.813253. eCollection 2022.
Colorectal cancer (CRC) is one of the most prevalent malignances worldwide. However, CRC with situs inversus totalis (SCRC) is extremely rare, and molecular characterization of this disease has never been investigated.
Tumor tissue samples from 8 patients with SCRC and 33 CRC patients without situs inversus totalis (NSCRC) were subjected to multigene next-generation sequencing.
The most frequently mutated genes in SCRC were , , , , , , and . A high frequency of SCRC tumors had mutations in DNA damage repair genes. Single amino acid substitutions in the DNA damage repair genes caused by continuous double base substitution was identified in the majority of this population. Furthermore, mutational profiles showed notable differences between the SCRC and NSCRC groups. In particular, , , , , , , , and mutations were more frequently observed in SCRC patients. The mutation loci distributions of in the SCRC cohort differed from that of the NSCRC cohort. Additionally, differences in the targeted genomic profiles and base substitution patterns were observed between the two groups.
These findings comprehensively revealed a molecular characterization of SCRC, which will contribute to the development of personalized therapy and improved clinical management of SCRC patients.
结直肠癌(CRC)是全球最常见的恶性肿瘤之一。然而,全内脏反位的结直肠癌(SCRC)极为罕见,且尚未对该疾病的分子特征进行研究。
对8例SCRC患者和33例无全内脏反位的CRC患者(NSCRC)的肿瘤组织样本进行多基因二代测序。
SCRC中最常发生突变的基因是 、 、 、 、 、 和 。SCRC肿瘤中DNA损伤修复基因发生突变的频率较高。在该人群的大多数个体中,鉴定出由连续双碱基替换导致的DNA损伤修复基因中的单氨基酸替换。此外,SCRC组和NSCRC组的突变谱存在显著差异。特别是, 、 、 、 、 、 、 和 突变在SCRC患者中更频繁地被观察到。SCRC队列中 的突变位点分布与NSCRC队列不同。此外,两组之间在靶向基因组图谱和碱基替换模式上也存在差异。
这些发现全面揭示了SCRC的分子特征,这将有助于SCRC患者个性化治疗的发展和改善临床管理。